Article
ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects.
European journal of clinical pharmacology - 1 Jan 2020
Cao Kangna, Ren Guanghui, Lu Chengcan, Wang Yao, Tan Yanan, Zhou Jing, Zhang Yongjie, Lu Yang, Li Ning, Chen Xijing, Zhao Di
Abstract excerpt
PURPOSE: Our aim was to evaluate the influence of genetic polymorphisms involved in the metabolism and transportation of deferasirox on deferasirox pharmacokinetics in the Chinese population. METHODS: Thirty-eight healthy Chinese subjects were administered with a single dose of 20 mg kg-1 deferasirox. Allelic discriminations for eight single-nucleotide polymorphisms (SNPs) in UDP-glucuronosyltransferase 1A1, 1A3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
